Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI65883

Blood pressure influences end-stage renal disease of Cd151 knockout mice

Norman Sachs, Nike Claessen, Jan Aten, Maaike Kreft, Gwendoline J.D. Teske, Anneke Koeman, Coert J. Zuurbier, Hans Janssen, and Arnoud Sonnenberg

Find articles by Sachs, N. in: PubMed | Google Scholar

Find articles by Claessen, N. in: PubMed | Google Scholar

Find articles by Aten, J. in: PubMed | Google Scholar

Find articles by Kreft, M. in: PubMed | Google Scholar

Find articles by Teske, G. in: PubMed | Google Scholar

Find articles by Koeman, A. in: PubMed | Google Scholar

Find articles by Zuurbier, C. in: PubMed | Google Scholar

Find articles by Janssen, H. in: PubMed | Google Scholar

Find articles by Sonnenberg, A. in: PubMed | Google Scholar

Published September 4, 2012 - More info

Published in Volume 122, Issue 9 on September 4, 2012
J Clin Invest. 2012;122(9):3368–3368. https://doi.org/10.1172/JCI65883.
© 2012 The American Society for Clinical Investigation
Published September 4, 2012 - Version history
View PDF

Related article:

Blood pressure influences end-stage renal disease of Cd151 knockout mice
Norman Sachs, … , Hans Janssen, Arnoud Sonnenberg
Norman Sachs, … , Hans Janssen, Arnoud Sonnenberg
Research Article

Blood pressure influences end-stage renal disease of Cd151 knockout mice

  • Text
  • PDF
Abstract

Podocytes of the kidney adhere tightly to the underlying glomerular basement membrane (GBM) in order to maintain a functional filtration barrier. The clinical importance of podocyte binding to the GBM via an integrin-laminin-actin axis has been illustrated in models with altered function of α3β1 integrin, integrin-linked kinase, laminin-521, and α-actinin 4. Here we expanded on the podocyte-GBM binding model by showing that the main podocyte adhesion receptor, integrin α3β1, interacts with the tetraspanin CD151 in situ in humans. Deletion of Cd151 in mouse glomerular epithelial cells led to reduced adhesive strength to laminin by redistributing α3β1 at the cell-matrix interface. Moreover, in vivo podocyte-specific deletion of Cd151 led to glomerular nephropathy. Although global Cd151-null B6 mice were not susceptible to renal disease, as has been shown previously, increasing blood and transcapillary filtration pressure induced nephropathy in these mice. Importantly, blocking the angiotensin-converting enzyme in renal disease–susceptible global Cd151-null FVB mice prolonged their median life span. Together, these results establish CD151 as a crucial modifier of integrin-mediated adhesion of podocytes to the GBM and show that blood pressure is an important factor in the initiation and progression of Cd151 knockout–induced nephropathy.

Authors

Norman Sachs, Nike Claessen, Jan Aten, Maaike Kreft, Gwendoline J.D. Teske, Anneke Koeman, Coert J. Zuurbier, Hans Janssen, Arnoud Sonnenberg

×

Original citation: J. Clin. Invest. 2012;122(1):348–358. doi:10.1172/JCI58878.

Citation for this corrigendum: J. Clin. Invest. 2012;122(9):3368. doi:10.1172/JCI65883.

During the preparation of this manuscript, funding information was inadvertently omitted. The sentence below should be added to Acknowledgments.

The study was supported by the Dutch Kidney Foundation (grant C07.2232).

The authors regret the error.

Version history
  • Version 1 (September 4, 2012): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts